Commonwealth Equity Services »

Halozyme Therapeutics shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $22k 20k 1.08

More positions owned by Commonwealth Equity Services

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Growth Etf Shs Creation Uni (CGGR)

View all positions for Commonwealth Equity Services

Top funds holding Halozyme Therapeutics

Millennium Management
Tenor Capital Management
M&G
Jpmorgan Chase & Co
Nuveen
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
FMR
Point72 Asset Management
Calamos Advisors
MacKay Shields
Angelo, Gordon & Co
Advent Capital Management
Sonora Investment Management Group
Colony
Water Island Capital

View all funds holding Halozyme Therapeutics